Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)-A 20-year observational studyGant, C. M., Mensink, I., Binnenmars, S. H., van der Palen, J. A. M., Bakker, S. J. L., Navis, G. & Laverman, G. D., 19-Jun-2019, In : PLoS ONE. 14, 6, 14 p., 0218400.
Research output: Contribution to journal › Article › Academic › peer-review
Although weight gain increases risk of type 2 diabetes, real-life data on the weight course in patients with established type 2 diabetes are scarce. We assessed weight course in a real-life diabetes secondary care setting and analyzed its association with patient characteristics, lifestyle habits and initiation of insulin, glucagon like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter-2 inhibitors (SGLT-2i).
Data on weight, insulin, GLP-1 RA and SGLT-2i use were collected retrospectively (12 years) and prospectively (8 years) from patients included in the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT-1, n = 450, age 63 +/- 9 years, 58% men, diabetes duration [7-18] years). Lifestyle habits were assessed using validated questionnaires. The association of clinical parameters with body mass index (BMI) course was determined using linear mixed models. Patients who underwent bariatric surgery (n = 19) had a distinct BMI course and were excluded from the study.
Baseline BMI was 31.3 (0.3) and was higher in women, patients aged
High BMI that real-life patients with type 2 diabetes gained earlier in life, remained stable in the following decades. Weight loss interventions should remain a priority, and GLP-1 RA might be considered to support weight loss.
|Number of pages||14|
|Publication status||Published - 19-Jun-2019|
- FAT MASS, TYPE-2, INTERVENTIONS, GAIN, AGE, QUESTIONNAIRE, ASSOCIATIONS, METAANALYSIS, VALIDITY, OUTCOMES